ConvaTec Group (CNVVY) Projected to Post Quarterly Earnings on Wednesday

ConvaTec Group (OTCMKTS:CNVVY) is expected to post its results before the market opens on Wednesday, February 25th. Analysts expect ConvaTec Group to post earnings of $0.40 per share and revenue of $1.2526 billion for the quarter.

ConvaTec Group Stock Performance

Shares of CNVVY opened at $12.33 on Monday. ConvaTec Group has a 12 month low of $11.28 and a 12 month high of $16.65. The stock’s 50-day moving average is $12.72 and its two-hundred day moving average is $12.71.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Peel Hunt upgraded ConvaTec Group from a “moderate buy” rating to a “strong-buy” rating in a report on Tuesday, October 28th. Sanford C. Bernstein upgraded shares of ConvaTec Group to a “strong-buy” rating in a research note on Wednesday, January 28th. Two research analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Strong Buy”.

About ConvaTec Group

ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.

Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.